Human trials begin for Army-developed Zika purified inactivated virus (ZPIV) vaccine

WRAIR scientists, who co-led development of the ZPIV vaccine, discuss WRAIR's efforts to create a vaccine and unique capabilities that enabled a rapid response.
Up Next
WRAIR scientists, who co-led development of the ZPIV vaccine, discuss WRAIR's efforts to create a vaccine and unique capabilities that enabled a rapid response.

Army scientists begin testing inactive Zika virus vaccine in humans

November 08, 2016 02:36 PM